FBIO Fortress Biotech Inc

Price (delayed)

$1.93

Market cap

$38.44M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.1

Enterprise value

$38.26M

Fortress Biotech, Inc. ("Fortress") is an innovative biopharmaceutical company that was ranked in Deloitte's 2019 and 2020 Technology Fast 500™, annual rankings of the fastest- growing North American companies in ...

Highlights
The gross profit has surged by 65% year-on-year
Fortress Biotech's EPS has surged by 63% YoY and by 28% QoQ
The company's equity fell by 39% YoY but it rose by 2.1% QoQ
FBIO's quick ratio is down by 23% YoY and by 6% QoQ

Key stats

What are the main financial stats of FBIO
Market
Shares outstanding
19.92M
Market cap
$38.44M
Enterprise value
$38.26M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.61
Price to sales (P/S)
0.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.45
Earnings
Revenue
$85.11M
EBIT
-$40.38M
EBITDA
-$31.95M
Free cash flow
-$104.46M
Per share
EPS
-$6.1
Free cash flow per share
-$6.09
Book value per share
$1.2
Revenue per share
$4.96
TBVPS
$8.46
Balance sheet
Total assets
$164.65M
Total liabilities
$168.58M
Debt
$85.66M
Equity
$23.03M
Working capital
$28.85M
Liquidity
Debt to equity
3.72
Current ratio
1.33
Quick ratio
1.09
Net debt/EBITDA
0.01
Margins
EBITDA margin
-37.5%
Gross margin
68.2%
Net margin
-64.1%
Operating margin
-141%
Efficiency
Return on assets
-37.9%
Return on equity
-311.3%
Return on invested capital
-94%
Return on capital employed
-52.5%
Return on sales
-47.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FBIO stock price

How has the Fortress Biotech stock price performed over time
Intraday
-2.03%
1 week
7.22%
1 month
-3.02%
1 year
-76.18%
YTD
-35.88%
QTD
12.87%

Financial performance

How have Fortress Biotech's revenue and profit performed over time
Revenue
$85.11M
Gross profit
$58.09M
Operating income
-$120.04M
Net income
-$54.52M
Gross margin
68.2%
Net margin
-64.1%
The gross profit has surged by 65% year-on-year
FBIO's operating margin has surged by 58% year-on-year and by 16% since the previous quarter
The net margin has soared by 55% YoY and by 11% QoQ
FBIO's operating income is up by 44% YoY and by 16% from the previous quarter

Growth

What is Fortress Biotech's growth rate over time

Valuation

What is Fortress Biotech stock price valuation
P/E
N/A
P/B
1.61
P/S
0.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.45
Fortress Biotech's EPS has surged by 63% YoY and by 28% QoQ
The P/B is 44% less than the 5-year quarterly average of 2.9 and 30% less than the last 4 quarters average of 2.3
The company's equity fell by 39% YoY but it rose by 2.1% QoQ
The P/S is 86% below the 5-year quarterly average of 2.7 and 22% below the last 4 quarters average of 0.5
FBIO's revenue is up by 32% year-on-year

Efficiency

How efficient is Fortress Biotech business performance
The company's return on equity has shrunk by 69% YoY and by 8% QoQ
Fortress Biotech's return on sales has surged by 60% YoY and by 11% QoQ
The ROA has declined by 18% year-on-year and by 5% since the previous quarter
FBIO's return on invested capital is down by 2.7% year-on-year

Dividends

What is FBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FBIO.

Financial health

How did Fortress Biotech financials performed over time
The total assets is 2.3% less than the total liabilities
The total assets has contracted by 38% YoY
FBIO's total liabilities is down by 31% year-on-year
The company's equity fell by 39% YoY but it rose by 2.1% QoQ
The debt has decreased by 30% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.